Cite
HARVARD Citation
Hernandez, A. et al. (2018). Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial. Lancet. 392 (10157), pp. 1519-1529. [Online].